ProQR Therapeutics N.V. (PRQR)
USD 2.57
(-12.59%)
USD 2.57
(-12.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.51 Million | 4.03 Million | 1.35 Million | - | 1.93 Million | 4.94 Million |
| Cost of Revenue | 133.52 Thousand | 2.47 Million | - | 2.19 Million | 116.82 Million | 983.51 Thousand |
| Gross Profit | 6.38 Million | 1.56 Million | 1.35 Million | -2.19 Million | -114.89 Million | 3.95 Million |
| Operating Expenses | 38.37 Million | 68.75 Million | 58.54 Million | 51.82 Million | 59.37 Million | 42.05 Million |
| Selling, General and Administrative Expenses | 16.23 Million | 18.65 Million | 17.36 Million | 13.68 Million | 12.88 Million | 12.54 Million |
| Research and Development Expenses | 25.14 Million | 50.86 Million | 42.22 Million | 38.13 Million | 46.49 Million | 29.51 Million |
| Other Expenses | -3.01 Million | -765 Thousand | -1.04 Million | 9.36 Million | 1.93 Million | 5.76 Million |
| Cost and Expenses | 38.37 Million | 68.75 Million | 58.54 Million | 51.82 Million | 59.37 Million | 42.05 Million |
| Operating Income | -31.85 Million | -64.71 Million | -57.19 Million | -42.36 Million | -57.44 Million | -36.29 Million |
| Interest Expense | 1.2 Million | 5.12 Million | 3.4 Million | 2.04 Million | 1.08 Million | 810 Thousand |
| Income Tax Expense | -78 Thousand | 96 Thousand | 117 Thousand | 124 Thousand | 132 Thousand | 1000.00 |
| Earnings before Tax | -27.81 Million | -64.79 Million | -61.56 Million | -46.49 Million | -56.61 Million | -37.08 Million |
| Net Income | -28.11 Million | -64.89 Million | -61.68 Million | -46.61 Million | -56.74 Million | -36.89 Million |
| Earnings Per Share Basic | -0.35 | -0.91 | -0.96 | -0.93 | -1.38 | -1.08 |
| Earnings Per Share Diluted | -0.35 | -0.91 | -0.96 | -0.93 | -1.38 | -1.08 |
| Weighted Average Shares Outstanding | 81.01 Million | 71.64 Million | 64.18 Million | 50.06 Million | 41.03 Million | 34.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.01 Million | 71.64 Million | 64.18 Million | 50.06 Million | 41.03 Million | 34.05 Million |
| Gross Margin | 0.98 | 0.39 | 1.00 | - | -59.44 | 0.80 |
| EBIT Margin | -3.70 | -14.71 | -40.90 | - | -29.66 | -8.31 |
| Profit Margin | -4.32 | -16.07 | -45.55 | - | -29.36 | -7.47 |
| EBITDA | -24.09 Million | -56.46 Million | -54.94 Million | -136.55 Million | -174.26 Million | -35.29 Million |
| Earnings Before Tax Margin | -4.89 | -16.03 | -42.24 | - | -29.72 | -7.35 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.33 Million | 4.47 Million | 6.38 Million | 3.19 Million | 1.37 Million | 1.2 Million |
| Cost of Revenue | 714.59 Thousand | 695.06 Thousand | - | - | - | - |
| Gross Profit | 5.62 Million | 3.78 Million | 6.38 Million | 3.19 Million | 1.37 Million | 1.2 Million |
| Operating Expenses | 9.39 Million | 12.11 Million | 38.07 Million | 11.45 Million | 8.76 Million | 10.05 Million |
| Selling, General and Administrative Expenses | 2.31 Million | 2.77 Million | - | 3.91 Million | 3.31 Million | 4.14 Million |
| Research and Development Expenses | 7.08 Million | 9.33 Million | - | 7.53 Million | 5.44 Million | 5.9 Million |
| Other Expenses | 351 Thousand | -68 Thousand | 953 Thousand | -56 Thousand | 118 Thousand | 259 Thousand |
| Cost and Expenses | 10.11 Million | 12.8 Million | 40.53 Million | 12.16 Million | 8.76 Million | 10.05 Million |
| Operating Income | -3.77 Million | -8.33 Million | -34.15 Million | -8.96 Million | -7.39 Million | -8.81 Million |
| Interest Expense | - | - | 1.14 Million | - | - | - |
| Income Tax Expense | -201.01 Thousand | 3017.66 | -76.4 Thousand | 4871.71 | -41 Thousand | -42 Thousand |
| Earnings before Tax | -2.9 Million | -7.7 Million | -27.24 Million | -5.33 Million | -5.46 Million | -8.01 Million |
| Net Income | -2.7 Million | -7.7 Million | -27.54 Million | -5.34 Million | -5.71 Million | -7.99 Million |
| Earnings Per Share Basic | -0.03 | -0.09 | - | -0.07 | -0.07 | -0.10 |
| Earnings Per Share Diluted | -0.03 | -0.09 | - | -0.07 | -0.07 | -0.10 |
| Weighted Average Shares Outstanding | 81.66 Million | 81.57 Million | 81.01 Million | 78.46 Million | 81 Million | 80.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.66 Million | 81.57 Million | 81.01 Million | 78.46 Million | 81 Million | 80.93 Million |
| Gross Margin | 0.89 | 0.84 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -0.48 | -1.71 | - | -2.58 | -5.98 | -6.93 |
| Profit Margin | -0.43 | -1.72 | -4.32 | -1.67 | -4.17 | -6.63 |
| EBITDA | -3.06 Million | -7.63 Million | - | -8.25 Million | -8.19 Million | -8.35 Million |
| Earnings Before Tax Margin | -0.60 | -1.86 | -5.35 | -2.80 | -5.39 | -7.31 |
NSA-PA
CU6
SPLIL
301181
PIG
GRHI